<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04698889</url>
  </required_header>
  <id_info>
    <org_study_id>Tessari Protocol 1</org_study_id>
    <nct_id>NCT04698889</nct_id>
  </id_info>
  <brief_title>Effect of Ingestion of Human, Cow, and Modified-cow Milk, on Glucose and Hormone Responses in Humans.</brief_title>
  <acronym>PROLAT</acronym>
  <official_title>Study of the Effects of Ingestion of Natural Human, Natural Cow, and Modified-cow Milk, on Glucose, Amino Acids, Insulin, and Incretin Responses in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human milk, despite a much lower protein content, is as effective as cow milk on insulin&#xD;
      stimulation under iso-lactose conditions. The causes for such a similar potency are unknown.&#xD;
      This effect could be due to incretin and amino-acid responses, and/or to milk-protein&#xD;
      interactions.In this study the investigators will address the above question(s) by testing,&#xD;
      in young healthy volunteers, the effects of natural cow and human milk, as well as of the&#xD;
      manipulation of the casein and whey protein content in cow milk, on insulin, C-peptide, GLP-1&#xD;
      and GIP secretion, as well as on circulating amino acids.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To determine plasma glucose, insulin, C-peptide, glucagon-like polypeptide-1&#xD;
      (GLP-1), glucose-inhibitory-polypeptide (GIP) and amino-acid responses, following&#xD;
      administration of human and cow milk, either natural or with experimentally-modified casein&#xD;
      and whey-protein content(s).&#xD;
&#xD;
      Design. Young healthy volunteers of both sexes will receive iso-lactose loads (0.36 g lactose&#xD;
      / kg body weight) of: natural cow milk; natural human milk; and of cow milk with modified&#xD;
      casein and whey protein contents. Blood samples will be frequently collected over 4 hours.&#xD;
      Plasma glucose, amino acids, insulin and incretin concentrations will be measured.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 7, 2015</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Subjects allocated to receive one or more milk types in random order on different occasions, spaced by at least two weeks</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma insulin and c-peptide</measure>
    <time_frame>1 year</time_frame>
    <description>microunits and nanomoles</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma GIP: glucose-inhibitory polypeptide and GLP-1: glucagon-like-polypeptide-1</measure>
    <time_frame>1 year</time_frame>
    <description>picomol/L and picogram/mL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma Amino acids</measure>
    <time_frame>2 years</time_frame>
    <description>micromol/L</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Insulin Tolerance</condition>
  <condition>Hormone</condition>
  <condition>Aminoacidaemia</condition>
  <arm_group>
    <arm_group_label>Cow milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of natural cow whole milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Human milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of natural human milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modified cow milk - low protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of modified cow milk at low protein content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modified cow milk - high protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of modified cow milk at high protein content</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>natural cow</intervention_name>
    <arm_group_label>Cow milk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high protein cow milk</intervention_name>
    <arm_group_label>Modified cow milk - high protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>natural human</intervention_name>
    <arm_group_label>Human milk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low protein cow milk</intervention_name>
    <arm_group_label>Modified cow milk - low protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 20-35 yrs&#xD;
&#xD;
          -  Both sexes&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  In post-absorptive state&#xD;
&#xD;
          -  Hemoglobin Hb1c values within normal values.&#xD;
&#xD;
          -  Previous regular, moderate physical activity&#xD;
&#xD;
          -  Stable body weight and regular dietary habits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Familial or personal history of diabetes.&#xD;
&#xD;
          -  Altered fasting glucose and/ or impaired glucose tolerance.&#xD;
&#xD;
          -  Any metabolic, hormonal, hepatic, renal, and cardiovascular disease.&#xD;
&#xD;
          -  Current drug treatments&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>January 6, 2021</last_update_submitted>
  <last_update_submitted_qc>January 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Padova</investigator_affiliation>
    <investigator_full_name>Tessari Paolo</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <keyword>cow milk</keyword>
  <keyword>human milk</keyword>
  <keyword>incretins</keyword>
  <keyword>casein</keyword>
  <keyword>whey proteins</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 12, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT04698889/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 12, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT04698889/Prot_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 12, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT04698889/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

